Ngā hua rapu - Ghalib, Reem

Analysis of Gender Equity in Leadership of Physician-Focused Medical Specialty Societies, 2008-2017 mā Silver, Julie K., Ghalib, Reem, Poorman, Julie A., Al-Assi, Dana, Parangi, Sareh, Bhargava, Hansa, Shillcutt, Sasha K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Survey of Women Physicians' Experience with Elected Leadership Positions mā Shillcutt, Sasha K., Parangi, Sareh, Diekman, Sarah, Ghalib, Reem, Schoenthaler, Robin, Girgis, Linda M., Parekh, Ranna, Bhargava, Hansa, Silver, Julie K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2) mā Lawitz, Eric, Matusow, Gary, DeJesus, Edwin, Yoshida, Eric M., Felizarta, Franco, Ghalib, Reem, Godofsky, Eliot, Herring, Robert W., Poleynard, Gary, Sheikh, Aasim, Tobias, Hillel, Kugelmas, Marcelo, Kalmeijer, Ronald, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Sinha, Rekha, Witek, James

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence mā Zamor, Philippe J., Brown, Ashley, Dylla, Douglas E., Dillon, John F., Luetkemeyer, Anne F., Feld, Jordan J., Mutimer, David, Ghalib, Reem, Crown, Eric, Lovell, Sandra S., Hu, Yiran, Moreno, Christophe, Nelson, David R., Colombo, Massimo, Papatheodoridis, Georgios, Rockstroh, Juergen K., Skoien, Richard, Lawitz, Eric, Jacobson, Ira M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Racial Differences in Hepatitis C Treatment Eligibility mā Melia, Michael T., Muir, Andrew J., McCone, Jonathan, Shiffman, Mitchell L., King, John W., Herrine, Steven K., Galler, Greg W., Bloomer, Joseph R., Nunes, Frederick A., Brown, Kimberly A., Mullen, Kevin D., Ravendhran, Natarajan, Ghalib, Reem H., Boparai, Navdeep, Jiang, Ruiyun, Noviello, Stephanie, Brass, Clifford A., Albrecht, Janice K., McHutchison, John G., Sulkowski, Mark S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study mā Nelson, David R, Cooper, James N, Lalezari, Jacob P, Lawitz, Eric, Pockros, Paul J, Gitlin, Norman, Freilich, Bradley F, Younes, Ziad H, Harlan, William, Ghalib, Reem, Oguchi, Godson, Thuluvath, Paul J, Ortiz-Lasanta, Grisell, Rabinovitz, Mordechai, Bernstein, David, Bennett, Michael, Hawkins, Trevor, Ravendhran, Natarajan, Sheikh, Aasim M, Varunok, Peter, Kowdley, Kris V, Hennicken, Delphine, McPhee, Fiona, Rana, Khurram, Hughes, Eric A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa